Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-08-15 Sale | 2023-08-17 4:23 pm | Lyell Immunopharma Inc. | LYEL | Klausner Richard Director | 58,020 | $2.28 | $132,286 | 3,898,714 (Indirect Direct) | View |
2022-09-23 Sale | 2022-09-27 6:14 pm | Lyell Immunopharma Inc. | LYEL | Klausner Richard Director | 11,100 | $6.4001 | $71,041 | 3,956,734 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-14 Option Award | 2024-06-17 4:15 pm | N/A 2034-06-13 | Lyell Immunopharma Inc. | LYEL | Klausner Richard Director | 130,000 | $0 | 3,783,199 (Direct) | View |
2023-09-08 Option Award | 2023-09-08 4:30 pm | N/A 2033-09-07 | Lyell Immunopharma Inc. | LYEL | Klausner Richard Director | 55,000 | $0 | 3,953,714 (Direct) | View |
2023-06-16 Option Award | 2023-06-20 4:45 pm | N/A 2033-06-15 | Lyell Immunopharma Inc. | LYEL | Klausner Richard Director | 65,000 | $0 | 4,021,734 (Direct) | View |
2022-06-08 Option Award | 2022-06-10 4:08 pm | N/A 2032-06-07 | Lyell Immunopharma Inc. | LYEL | Klausner Richard Director | 65,000 | $0 | 4,032,834 (Direct) | View |
2021-06-21 Conversion | 2021-06-23 5:36 pm | N/A N/A | Lyell Immunopharma Inc. | LYEL | Klausner Richard Executive Chairman | 3,765,842 | $0 | 6,733,676 (Indirect) | View |
Ownership | 2021-06-16 7:18 pm | N/A N/A | Lyell Immunopharma Inc. | LYEL | Klausner Richard Executive Chairman | 0 | $0 | 14,772,824 (Direct) | View |